Stock Taper
SCREENER COMPARE ANY 2 STOCKS
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
NYSE
$36.44
▼ DOWN 3.14% (-1.18)

KEY STATISTICS

Market Cap$42.44 B
52w High$38.37
52w Low$18.14
Dividend Yield5.80%
FrequencyQuarterly
P/E12.44
Volume3.14M
Shares Out.1.16B

COMPANY

LEADERSHIP

Richard D. Francis
CHIEF EXECUTIVE
Richard D. Francis

COMPENSATION 2026

Salary$1,600,000
Stock Awards$8,999,988
Incentive Plan Pay$2,885,100
All Other Comp.$533,859
Total$15,518,947

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 16, 1982
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
32,008

PRICE TARGET

Target High$44.00
Target Low$42.00
Target Median$42.00
Target Consensus$42.67

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$4.23B
NOV
4
WED

SPLIT RECORD

DATETYPERATIO
2004-07-01Forward2:1
2002-12-06Forward2:1
2000-02-23Forward2:1
1993-04-14Forward2:1
1982-08-16Forward7:5

PRICE

$36.44 ▼ DOWN 3.14% (−$1.18)
OVERLAYS
$36.60$36.90$37.209:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM36.44

About Teva Pharmaceutical Industries Limited

https://www.tevapharm.com ↗

Teva Pharmaceutical Industries, founded in 1901 and based in Tel Aviv, develops, manufactures, and markets generic, specialty, and biopharmaceutical products worldwide, focusing on CNS, pain, respiratory, and oncology treatments across various dos...

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT TEVA PHARMACEUTICAL INDUSTRIES LIMITED IS KNOWN FOR

UZEDY® (risperidone) extended-release injectable suspension
UZEDY® (risperidone) extended-release injectable suspension

UZEDY® is a long-acting injectable schizophrenia treatment by Teva, administered monthly or bi-monthly, and is a rapidly growing, innovative brand addressing adherence challenges in adult patients.

COMPETITORS

COMPETITOR
ALKS COMPARE
AMRX COMPARE
JNJ COMPARE
LLY COMPARE

Revenue by Products

IconPRODUCTQ2-2025Q3-2025Q4-2025Q1-2026
Product$3.64B $3.91B ▲$3.67B ▼$3.39B ▼
Distribution Service$377M $406M ▲$384M ▼$396M ▲
Product and Service Other$117M $121M ▲$109M ▼$157M ▲
License$46M $46M $550M ▲$39M ▼

Revenue by Geography

MapREGIONQ2-2025Q3-2025Q4-2025Q1-2026
United States Segment$2.15B $2.48B ▲$4.55B ▲$1.53B ▼
Europe Segment$1.3B $1.24B ▼$1.31B ▲$1.34B ▲
International Markets$495M $557M ▲$528M ▼$524M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
269
LISTED HERE
26
RANKED BY POSITION SIZE
IEFA
0.17% · 8.7M
SCHF
0.14% · 2.7M
WCMI
3.32% · 1.8M
SPDW
0.12% · 1.4M
IDVO
2.45% · 958.4K
PPH
3.26% · 887.7K
LSPX.L
0.07% · 597.7K
IDMO
0.51% · 594.1K
XDWH.L
0.51% · 548.9K
VGS.AX
0.05% · 533.1K
ZEA.TO
0.19% · 492.8K
AVDE
0.10% · 489.5K
HMWO.L
0.09% · 469.7K
DIHP
0.18% · 318.9K
PCEB
1.64% · 300.0K
WRDUSW.SW
0.05% · 221.2K
GSIE
0.08% · 133.5K
IMOM
2.10% · 88.8K
FRTY
1.90% · 77.9K
CGNG
0.09% · 71.8K
IZRL
1.89% · 68.3K
SFTX
0.27% · 56.9K
DRFD.TO
0.70% · 47.7K
APIE
0.13% · 40.4K
JHMD
0.14% · 36.0K
AADR
2.84% · 30.3K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
41.34%
HOLDERS
1,057
TOP 12 OF 1,057 · RANKED BY POSITION SIZE
Blackrock, Inc.
65.1M sh · $1.96B
Harel Insurance Investments & Financial Services Ltd.
48.1M sh · $1.63B
Blackrock Inc.
43.0M sh · $698.55M
Phoenix Holdings Ltd.
42.9M sh · $1.45B
Wcm Investment Management, LLC
41.3M sh · $1.38B
Clal Insurance Enterprises Holdings Ltd
40.6M sh · $1.37B
Menora Mivtachim Holdings Ltd.
39.9M sh · $1.35B
Migdal Insurance & Financial Holdings Ltd.
38.9M sh · $1.32B
Norges Bank
35.2M sh · $1.1B
Fmr LLC
33.1M sh · $997.96M
Exor Capital Llp
28.6M sh · $577.49M
Rubric Capital Management LP
24.6M sh · $497.93M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity4
Return On Assets3
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Greg Gianforte
Greg Gianforte
Purchase
2020-11-13
 Donna Shalala
Donna Shalala
Sale (Full)
2020-05-07
 David E. Price
David E. Price
Sale (Full)
2019-06-19
SENATE TRADES
Patty Murray
Patty Murray
Sale (Full)
2017-06-15

INSIDER TRADES

★
OFFICER: CHIEF ACCOUNTING OFFICER
Weiss Amir
Purchase · 2.5K shares
2026-08-21
★
OFFICER: CHIEF ACCOUNTING OFFICER
Weiss Amir
Sale · 6.9K shares
2026-08-21
★
OFFICER: CHIEF ACCOUNTING OFFICER
Weiss Amir
Sale · 2.5K shares
2026-08-21
★
DIRECTOR
Satchi-Fainaro Ronit
Sale · 415 shares
2026-08-21

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 5
OVERWEIGHT 3
SECTOR OUTPERFORM 1
9 GRADES IN THE LAST 12 MONTHS
Barclays OVERWEIGHT Piper Sandler OVERWEIGHT UBS BUY JP Morgan OVERWEIGHT Truist Securities BUY B of A Securities BUY Goldman Sachs BUY Scotiabank SECTOR OUTPERFORM

SECTORS PEERS

PEERPRICE
NTRA$326.26COMPARE
DXCM$90.82COMPARE
BIIB$218.50COMPARE
WAT$414.69COMPARE
LH$335.11COMPARE
PHG$26.72COMPARE
BNTX$102.08COMPARE
STE$233.78COMPARE